Rhythm Pharmaceuticals, Inc. (RYTM) has a market capitalization of $5.96B and trades at $87.28. The 52-week range is 45.905-122.2.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -28.1, Earnings Per Share (EPS) of $-3.11, annual revenue of $189.76M.
The stock has a beta of 2.14, operates in the Healthcare sector.
